Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP/PS1 mice
- PMID: 28285172
- DOI: 10.1016/j.ejps.2017.03.010
Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP/PS1 mice
Abstract
Multifunctional liposomes (mf-LIPs) having a curcumin-lipid ligand (to target amyloids) together with two ligands to target the transferrin, and the low-density apolipoprotein receptor of the blood-brain-barrier (BBB) on their surface, were previously studied (in vitro) as potential theranostic systems for Alzheimer's disease (AD) (Papadia et al., 2017, Eur. J. Pharm. Sciences; 101:140-148). Herein, the targeting potential of mf-LIPs was compared to that of BBB-LIPs (liposomes having only the two BBB-specific ligands) in FVB mice (normal), as well as in double transgenic mice (APP/PS1) and their corresponding littermates (WT), by live-animal (in vivo) and explanted organ (ex vivo) imaging. In FVB mice, the head-signals of mf-LIPs and BBB-LIPs are either similar, or signals from mf-LIP are higher, suggesting that the co-presence of the curcumin derivative on the liposome surface does not disturb the functionality of the BBB-specific ligands. Higher brain/liver+spleen ratios (ex vivo) were calculated post-injection of mf-LIP, compared to those found after BBB-LIP injection, due to the reduced distribution of mf-LIPs in the liver and spleen; showing that the curcumin ligand increases the stealth properties of liposomes by reducing their uptake by liver and spleen. The later effect is more pronounced when the density of the BBB-specific ligands on the mf-LIPs is 0.1mol%, compared to 0.2%, highlighting the importance of this parameter. When a high lipid dose (4mg/mouse) is injected in WT and APP/PS1 mice, the head-signals of mf-LIPs are significantly higher than those of BBB-LIPs, but no differences are observed between WT and APP/PS1 mice. However, after administration of a low liposome dose (0.05mg/mouse) of mf-LIPs, significant differences in the head-signals are found between WT and transgenic mice, highlighting the AD theranostic potential of the multifunctional liposomes, as well as the importance of the experimental parameters used in such in vivo screening studies.
Keywords: Brain; Curcumin; Liposome; Live imaging; Multifunctional; Nanoparticle.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Multifunctional LUV liposomes decorated for BBB and amyloid targeting. A. In vitro proof-of-concept.Eur J Pharm Sci. 2017 Apr 1;101:140-148. doi: 10.1016/j.ejps.2017.02.019. Epub 2017 Feb 11. Eur J Pharm Sci. 2017. PMID: 28193538
-
Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease.Eur J Med Chem. 2014 Jun 10;80:175-83. doi: 10.1016/j.ejmech.2014.04.050. Epub 2014 Apr 18. Eur J Med Chem. 2014. PMID: 24780594
-
Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice.Int J Nanomedicine. 2020 Apr 23;15:2841-2858. doi: 10.2147/IJN.S239608. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32425521 Free PMC article.
-
Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jan-Feb;2(1):35-47. doi: 10.1002/wnan.59. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010. PMID: 20049829 Review.
-
Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease.J Control Release. 2017 Aug 28;260:61-77. doi: 10.1016/j.jconrel.2017.05.019. Epub 2017 May 24. J Control Release. 2017. PMID: 28549949 Review.
Cited by
-
Preparation, Physicochemical Properties, and In Vitro Toxicity towards Cancer Cells of Novel Types of Arsonoliposomes.Pharmaceutics. 2020 Apr 6;12(4):327. doi: 10.3390/pharmaceutics12040327. Pharmaceutics. 2020. PMID: 32268585 Free PMC article.
-
Muscone/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma.Theranostics. 2020 Mar 4;10(10):4308-4322. doi: 10.7150/thno.41322. eCollection 2020. Theranostics. 2020. PMID: 32292496 Free PMC article.
-
Transportation of Single-Domain Antibodies through the Blood-Brain Barrier.Biomolecules. 2021 Jul 31;11(8):1131. doi: 10.3390/biom11081131. Biomolecules. 2021. PMID: 34439797 Free PMC article. Review.
-
Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression.Mater Today Bio. 2023 Jun 17;21:100701. doi: 10.1016/j.mtbio.2023.100701. eCollection 2023 Aug. Mater Today Bio. 2023. PMID: 37415846 Free PMC article. Review.
-
The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation.Biomolecules. 2020 Oct 1;10(10):1401. doi: 10.3390/biom10101401. Biomolecules. 2020. PMID: 33019651 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources